{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-023069","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2026-05-14T20:05:32+00:00","discovered_at":"2026-05-14T20:07:00.245507+00:00","generated_at":"2026-05-14T21:01:37.931777+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aspire Biopharma files 1-for-30 reverse stock split","bullets":["Filed 1-for-30 reverse stock split of common stock on May 11, 2026.","Fractional shares rounded up; no fractional shares will be issued in the split.","Ticker symbol remains ASBP; new CUSIP number is 738920305.","Effective date set in the Certificate of Amendment filed with Delaware Secretary of State."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-023069","json":"https://secwatch.observer/filing/0001493152-26-023069.json","markdown":"https://secwatch.observer/filing/0001493152-26-023069.md","text":"https://secwatch.observer/filing/0001493152-26-023069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226023069/0001493152-26-023069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226023069/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T21:01:37.931777+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"246f387b56718eecebfc49c1f45653d8c655ca5b","claim":"Aspire Biopharma Holdings, Inc.: Amended Article Fourth of Certificate of Incorporation to effect a 1-for-30 reverse stock split (effective 2026-05-11).","evidence_excerpt":"On May 11, 2026, Aspire Biopharma Holdings, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Certificate of Incorporation (the “Certificate of Amendment”). Pursuant to the Certificate of Amendment, the Company amended Article Fourth of its Certificate of Incorporation to effect a 1-for-30 reverse stock split of the Company’s issued and outstanding common stock (the “Reverse Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226023069/0001493152-26-023069-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2026-05-11"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}